agilon health, inc. (NYSE:AGL) Given Average Rating of “Hold” by Brokerages

Shares of agilon health, inc. (NYSE:AGL) have been assigned an average rating of “Hold” from the seventeen brokerages that are currently covering the firm, MarketBeat.com reports. Two research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and two have assigned a buy rating to the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is $3.95.

AGL has been the subject of several recent analyst reports. Sanford C. Bernstein boosted their target price on agilon health from $2.50 to $3.15 and gave the company a “market perform” rating in a research report on Wednesday, January 15th. Royal Bank of Canada boosted their target price on agilon health from $3.00 to $3.50 and gave the company an “outperform” rating in a research report on Wednesday, February 26th. Macquarie initiated coverage on agilon health in a research report on Monday, December 16th. They set a “neutral” rating and a $3.00 target price for the company. Stifel Nicolaus boosted their target price on agilon health from $2.00 to $3.00 and gave the company a “hold” rating in a research report on Wednesday, February 26th. Finally, JMP Securities lowered agilon health from an “outperform” rating to a “market perform” rating in a report on Monday, November 11th.

agilon health Stock Down 1.0 %

Shares of NYSE:AGL opened at $3.50 on Monday. agilon health has a 1 year low of $1.50 and a 1 year high of $7.73. The business has a 50 day simple moving average of $3.11 and a two-hundred day simple moving average of $2.94. The firm has a market capitalization of $1.44 billion, a PE ratio of -3.72 and a beta of 0.67. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29.

Insider Buying and Selling

In other agilon health news, Director Karen Mcloughlin acquired 25,000 shares of agilon health stock in a transaction that occurred on Friday, December 13th. The stock was bought at an average price of $2.20 per share, with a total value of $55,000.00. Following the completion of the purchase, the director now directly owns 73,166 shares of the company’s stock, valued at approximately $160,965.20. This represents a 51.90 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 3.20% of the stock is currently owned by insiders.

Hedge Funds Weigh In On agilon health

Large investors have recently bought and sold shares of the business. Oak Thistle LLC acquired a new position in shares of agilon health during the fourth quarter worth $25,000. Ieq Capital LLC acquired a new position in shares of agilon health during the fourth quarter worth $26,000. Signaturefd LLC increased its position in shares of agilon health by 143.0% during the fourth quarter. Signaturefd LLC now owns 14,388 shares of the company’s stock worth $27,000 after purchasing an additional 8,467 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of agilon health during the third quarter worth $28,000. Finally, Humankind Investments LLC acquired a new position in shares of agilon health during the fourth quarter worth $30,000.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.